Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
US Army
Chubb
Teva
Fuji
Johnson and Johnson
Cipla
Accenture
Daiichi Sankyo
Fish and Richardson

Generated: October 18, 2017

DrugPatentWatch Database Preview

Capsaicin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for capsaicin and what is the scope of capsaicin patent protection?

Capsaicin
is the generic ingredient in one branded drug marketed by Acorda and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Capsaicin has sixteen patent family members in ten countries.

There are five drug master file entries for capsaicin. Two suppliers are listed for this compound.

Summary for Generic Name: capsaicin

US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list5
Suppliers / Packagers: see list2
Bulk Api Vendors: see list95
Clinical Trials: see list136
Patent Applications: see list7,733
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:capsaicin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acorda
QUTENZA
capsaicin
PATCH;TOPICAL022395-001Nov 16, 2009RXYesYes► Subscribe► Subscribe► Subscribe
Acorda
QUTENZA
capsaicin
PATCH;TOPICAL022395-001Nov 16, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: capsaicin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,248,788 Therapeutic method with capsaicin and capasicin analogs► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: capsaicin

Country Document Number Estimated Expiration
Denmark1039802► Subscribe
Germany69836352► Subscribe
European Patent Office1316308► Subscribe
Spain2196640► Subscribe
Portugal1039802► Subscribe
Austria344023► Subscribe
Hong Kong1030853► Subscribe
World Intellectual Property Organization (WIPO)9930560► Subscribe
European Patent Office1039802► Subscribe
Germany69814917► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Farmers Insurance
Queensland Health
Moodys
Deloitte
Healthtrust
Daiichi Sankyo
Fuji
Julphar
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot